FDA Eases Clinical Requirements For Some Computer-Assisted Detection Devices
This article was originally published in The Gray Sheet
Executive Summary
Two final guidance documents offer some wiggle room for makers of computer-assisted detection devices used in radiology.
You may also be interested in...
No Clinical Data Needed For Some Computer-Aided Detection Devices - Panel
Clinical performance studies may not be necessary for all new or modified computer-aided detection tools used in radiology applications, an FDA advisory panel concluded Nov. 18
FDA Refines Requirements For Computer-Aided Detection
FDA published two draft guidance documents Oct. 21 to help firms through 510(k) or PMA submissions for computer-aided detection tools; on the following day, the agency announced an upcoming panel meeting on the topic
Executives On The Move: Changes At The Top At Enzolytics, Dyne Therapeutics And Seres Therapeutics
Recent moves in the industry include new chief financial officers at LENZ Therapeutics and Botanix Pharmaceuticals, plus new chief medical officers at Vigil Neuroscience and Voyager Therapeutics.